RA Capital Management - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,131,105
-22.4%
5,914,2520.0%0.09%
-13.0%
Q4 2022$5,322,827
-85.0%
5,914,2520.0%0.11%
-85.7%
Q3 2022$35,486,000
+44.9%
5,914,2520.0%0.76%
+15.9%
Q2 2022$24,485,000
+8.9%
5,914,2520.0%0.65%
+33.3%
Q1 2022$22,474,000
-15.6%
5,914,2520.0%0.49%
+4.5%
Q4 2021$26,614,000
-3.4%
5,914,2520.0%0.47%
+22.8%
Q3 2021$27,560,000
-33.9%
5,914,2520.0%0.38%
-42.9%
Q2 2021$41,695,000
+19.3%
5,914,2520.0%0.67%
+26.9%
Q1 2021$34,953,000
+61.9%
5,914,252
+26.3%
0.53%
+74.5%
Q4 2020$21,583,000
+18.5%
4,681,8580.0%0.30%
-9.3%
Q3 2020$18,212,000
-86.5%
4,681,8580.0%0.33%
-87.3%
Q2 2020$134,650,000
+33.6%
4,681,8580.0%2.62%
-17.6%
Q1 2020$100,754,000
+9.4%
4,681,8580.0%3.18%
+13.9%
Q4 2019$92,139,000
+31.1%
4,681,8580.0%2.79%
-33.3%
Q3 2019$70,275,0004,681,8584.19%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,711,286$22,268,0003.58%
NEA Management Company, LLC 3,142,958$18,858,0000.94%
Vivo Capital, LLC 1,232,394$7,394,0000.82%
RA Capital Management 5,914,252$35,486,0000.76%
Nan Fung Group Holdings Ltd 177,900$1,067,0000.68%
Ikarian Capital, LLC 400,000$2,400,0000.48%
SAMLYN CAPITAL, LLC 2,929,195$17,575,0000.33%
EAM Investors, LLC 149,029$894,0000.19%
TPG GP A, LLC 1,885,939$11,316,0000.18%
Ikarian Capital, LLC 136,059$815,0000.16%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders